New radiosensitizing regimens, drugs, prodrugs, and candidates.

Clinical advances in hematology & oncology : H&O

Volumn 2, Issue 12, 2004, Pages 793-805

  Vallerga, Anne K ^a   Zarling, David A ^a   Kinsella, Timothy J ^a  

^a Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PRODRUG; RADIOSENSITIZING AGENT;

ADJUVANT THERAPY; DRUG DELIVERY SYSTEM; HUMAN; MULTIMODALITY CANCER THERAPY; NEOPLASM; REVIEW;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DRUG DELIVERY SYSTEMS; HUMANS; NEOPLASMS; PRODRUGS; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY, ADJUVANT;

EID: 26944442433     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (140)